VKTX Viking Therapeutics, Inc.
$30.51
Viking Therapeutics, Inc. (VKTX) Earnings News
Earnings press releases, previews and reviews for Viking Therapeutics, Inc. (VKTX), newest first.
Tuesday
September 22, 2026
7:05 AM ET
Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens
Wednesday
July 29, 2026
4:05 PM ET
Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Wednesday
July 22, 2026
4:05 PM ET
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026
Wednesday
April 29, 2026
4:05 PM ET
Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Wednesday
April 22, 2026
4:35 PM ET
Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026